Matching slides 110,539
Current window 91,291-91,320
Pages 3,685
Rows per page 30
Component: Listclear collectionreset all

Component

91,291-91,320 of 110,539

filter-aware
74
The slide uses a series of sparkline-like bar charts to show annual charge-off rates in basis points.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
75
Apollo Global Management | Investor Day Presentation Deck | 119 slidesApollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
83
The diagram illustrates the capital stack and risk tranching from underlying asset to ABS securitization.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
84
The slide uses two donut charts to represent market growth over a decade.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
87
The slide uses a donut chart to visualize portfolio breakdown by asset class.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
88
The slide uses a combination of a checklist for qualitative risk factors and big-number metrics for quantitative performance.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
89
The diagram uses a 2x2-style axis to position ATLAS SP as a central hub between Credit Funds and Banks.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
91
Apollo Global Management | Investor Day Presentation Deck | 119 slidesApollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
109
Apollo Global Management | Investor Day Presentation Deck | 119 slidesApollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
116
Page number 116 indicates this is part of a larger financial reporting deck.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
117
Page 117 of a larger presentation deck.Apollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
10
The slide uses a numbered list format to present key market observations.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
15
The slide uses a dual-axis chart to show the inverse relationship between bond supply and dealer liquidity, supported by anecdotal evidence of market crashes.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
20
The slide uses a process-like diagram to show how Apollo/Athene and 3rd-party investors converge on specific investment vehicles.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
25
The chart shows historical growth from 2020 to 3Q'23 LTM and a 2026 target.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
34
Includes governance principles and leadership team statistics as of September 30, 2023.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
35
The slide acts as a navigation hub for team-related content.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
04
The slide uses a column-based layout with icons and supporting text to present company strengths.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
08
The slide uses a process-flow diagram to show how different mechanisms of action (NA, RNAi, PD-L1 Inhibitor, Interferon, Vaccines) contribute to the three pillars of the therapeutic approach.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a bulleted list to summarize the therapeutic profile and a diagram to illustrate the mechanism of action targeting HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
The slide outlines trial design cohorts (E, F, G, I, J, K) and summarizes findings from parts 1 & 2.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
The table displays mean (SE) log10 IU/mL values for various cohorts (E, F, I, J, K, G) from baseline through follow-up week 48.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, highlighting individual subject responses.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
The slide displays 8 individual patient charts tracking biomarker levels over time, with specific annotations for NA retreatment.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a timeline-based process diagram to illustrate the randomization and treatment arms of the clinical trial.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
19
The slide outlines two distinct treatment arms involving Imdusiran, VTP-300, and Nivolumab.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
04
argenx SE | Investor Presentation Deck | 25 slidesargenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
The slide outlines a clinical trial protocol timeline.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
15
The slide outlines a clinical trial protocol with a 1-3 week screening phase followed by a 30-week treatment period.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit